Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free free
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Treatment of herpes zoster Opstelten W; Eekhof J; Neven AK; Verheij TCan Fam Physician 2008[Mar]; 54 (3): 373-7OBJECTIVE: To review the evidence regarding treatment of herpes zoster (HZ) in the short-term, focusing on the prevention of postherpetic neuralgia (PHN). QUALITY OF EVIDENCE: The evidence relating to treatment of HZ is derived mainly from randomized controlled trials (level I evidence). MAIN MESSAGE: Antiviral drugs might have some effect on the severity of acute pain and on the duration of skin lesions. Corticosteroids also alleviate acute pain. Oral antiviral medication reduces the risk of eye complications in patients with ophthalmic HZ. There is no convincing evidence that antiviral medication reduces the risk of PHN. Some studies, however, have shown that famciclovir and valacyclovir shorten the duration of PHN. The effectiveness of amitriptyline or cutaneous and percutaneous interventions in preventing PHN has not been proven. CONCLUSION: Oral antiviral drugs should be prescribed to elderly HZ patients with high risk of PHN. Moreover, these drugs should be prescribed to all patients at the first signs of ophthalmic HZ, irrespective of age or severity of symptoms.|2-Aminopurine/administration & dosage/analogs & derivatives/therapeutic use[MESH]|Acyclovir/administration & dosage/analogs & derivatives/therapeutic use[MESH]|Antiviral Agents/administration & dosage/*therapeutic use[MESH]|Famciclovir[MESH]|Glucocorticoids/administration & dosage/*therapeutic use[MESH]|Herpes Zoster Ophthalmicus/*drug therapy/prevention & control[MESH]|Herpes Zoster/*drug therapy[MESH]|Humans[MESH]|Neuralgia, Postherpetic/*drug therapy/prevention & control[MESH]|Prednisolone/administration & dosage/therapeutic use[MESH]|Time Factors[MESH]|Valacyclovir[MESH]|Valine/administration & dosage/analogs & derivatives/therapeutic use[MESH] |